UBS Group’s Celestica CLS Stock Holding History

UBS Group’s Portfolio CLS Stock Details CLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,738	Closed	-$428K	–	10573
2025 Q3	$428K	Buy	1,738 +200	+13%	+$40.3K	﹤0.01%	6209
2025 Q2	$240K	Buy	+1,538	New	+$163K	﹤0.01%	6596

Other funds holding CLS

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

CIBC World Market Toronto, Ontario, Canada $62.3B AUM 44.64% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $52.8B AUM 58.98% 1-Year Est. Return

VARA

Value Aligned Research Advisors Princeton, New Jersey $40.1B AUM 376.19% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

UBS Group's CLS Position: Q2 2026 in Review

UBS Group reduced its Celestica (CLS) stake by 7.5% in Q2 2026, selling an estimated $12.2M and leaving 402,735 shares worth $147M. The position accounts for 0.02% of the portfolio, ranked #866.

UBS Group first reported a position in CLS in Q4 2014 and has held it in 43 quarters since. 878 funds tracked by Wall St. Rank hold CLS as of Q2 2026.

UBS Group held 402,735 shares of Celestica worth $147M as of Q2 2026.
UBS Group sold 32,571 Celestica shares in Q2 2026, an estimated $12.2M.
Celestica made up 0.02% of UBS Group's portfolio in Q2 2026, its #866 holding.
UBS Group first reported a position in Celestica in Q4 2014 and has held it in 43 quarters since.
878 funds tracked by Wall St. Rank held Celestica as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.